Forbes August 27, 2021
William A. Haseltine

This is the eighth article in a 15-part series called “Relevance of Immune Suppression by SARS-CoV-2 to Understanding and Controlling the Covid-19 Pandemic,” which will explore an underappreciated but highly significant aspect of SARS-CoV-2 replication. The ability of SARS-CoV-2 to delay, evade, and suppress the immune system has myriad implications for drugs, vaccines, and other aspects of our pandemic response. The first set of pieces in this series are intended for a general audience; the second set, for the medical community; and the third and final set, for biomedical researchers looking for a deeper understanding of variants, how they’re generated, and what we might do to control them. Read parts 1, 2, 3, 4, 5, 6, and 7.

SARS-CoV-2 Multilevel...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech, Public Health / COVID
How To Prevent Alzheimer’s Disease: A Case For Vaccines
Obesity drugs could bankrupt US healthcare, says Sanders
First Wave BioPharma comes ashore with new name as it prepares for phase 3 trial
US Pharma and Biotech Summit 2024: A Biotech Industry Overview
AstraZeneca antibody reduced Covid-19 risk in immunocompromised

Share This Article